Contract manufacturing of small fill volume pharmaceutical unit dose sterile and non

Ritedose specializes in the aseptic production of sterile, single-dose medications, demonstrating a strong commitment to quality and reliability in the pharmaceutical manufacturing sector. With over 27 years of experience, the company has established itself as a leader in contract development and manufacturing organizations (CDMO), generics, and 503B outsourcing markets. Ritedose has successfully delivered more than 10 billion doses since 2012, maintaining an impeccable record of uninterrupted service. Their focus on meticulous controls and constant advancements in aseptic processing and environmental control ensures that every dose is produced with the utmost precision, reflecting their dedication to patient safety and care.

In addition to their core competencies in aseptic production, Ritedose offers on-demand services with next-day delivery options and extended dating for their products. The company has a proven track record of delivering 4.5 billion doses over the past decade without any errors or disruptions, showcasing their responsiveness and reliability in the industry. Ritedose emphasizes the importance of every detail in the medication development and delivery process, underscoring their commitment to honoring patients and healthcare providers alike. This dedication to excellence is evident in their operational practices and the technologies they employ to ensure the highest standards of safety and efficacy in their products.

United States

The Ritedose Corporation is a leader in blow-fill-seal(BFS) manufacturing of small fill volume pharmaceutical unit dose sterile and non-sterile liquids.

We specialize in manufacturing inhalation products, eye drops, eardrops and unit dose oral liquids.

Ritedose

Company Details